Global Dermatology Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
The Dermatology Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Dermatology Drug size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Dermatology Drug market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Dermatology Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Dermatology Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatology Drug, with price, sales, revenue and global market share of Dermatology Drug in 2018 and 2019.
Chapter 3, the Dermatology Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatology Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Dermatology Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Dermatology Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our latest research, the global Dermatology Drug size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Dermatology Drug market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Dermatology Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- External Use
- Oral
- Injection
- Psoriasis
- Skin Infections
- Acne
- Dermatitis
- Others
- AbbVie
- Johnson & Johnson
- Bayer
- Galderma
- Bristol-Myers Squibb
- Novartis
- Pfizer
- Merz Pharma
- Valeant
- LEO Pharma
- GlaxoSmithKline
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Dermatology Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatology Drug, with price, sales, revenue and global market share of Dermatology Drug in 2018 and 2019.
Chapter 3, the Dermatology Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatology Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Dermatology Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Dermatology Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Dermatology Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dermatology Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 External Use
1.2.3 Oral
1.2.4 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Dermatology Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Psoriasis
1.3.3 Skin Infections
1.3.4 Acne
1.3.5 Dermatitis
1.3.6 Others
1.4 Global Dermatology Drug Market Size & Forecast
1.4.1 Global Dermatology Drug Sales in Value (2016-2026))
1.4.2 Global Dermatology Drug Sales in Volume (2016-2026)
1.4.3 Global Dermatology Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Dermatology Drug Production Capacity Analysis
1.5.1 Global Dermatology Drug Total Production Capacity (2016-2026)
1.5.2 Global Dermatology Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dermatology Drug Market Drivers
1.6.2 Dermatology Drug Market Restraints
1.6.3 Dermatology Drug Trends Analysis
2 MANUFACTURERS PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Dermatology Drug Product and Services
2.1.4 AbbVie Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Dermatology Drug Product and Services
2.2.4 Johnson & Johnson Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Dermatology Drug Product and Services
2.3.4 Bayer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Galderma
2.4.1 Galderma Details
2.4.2 Galderma Major Business
2.4.3 Galderma Dermatology Drug Product and Services
2.4.4 Galderma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb Dermatology Drug Product and Services
2.5.4 Bristol-Myers Squibb Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Dermatology Drug Product and Services
2.6.4 Novartis Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Dermatology Drug Product and Services
2.7.4 Pfizer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Merz Pharma
2.8.1 Merz Pharma Details
2.8.2 Merz Pharma Major Business
2.8.3 Merz Pharma Dermatology Drug Product and Services
2.8.4 Merz Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Valeant
2.9.1 Valeant Details
2.9.2 Valeant Major Business
2.9.3 Valeant Dermatology Drug Product and Services
2.9.4 Valeant Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 LEO Pharma
2.10.1 LEO Pharma Details
2.10.2 LEO Pharma Major Business
2.10.3 LEO Pharma Dermatology Drug Product and Services
2.10.4 LEO Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Dermatology Drug Product and Services
2.11.4 GlaxoSmithKline Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 DERMATOLOGY DRUG SALES BY MANUFACTURER
3.1 Global Dermatology Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Dermatology Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Dermatology Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Dermatology Drug Manufacturer Market Share
3.4.2 Top 6 Dermatology Drug Manufacturer Market Share
3.5 Global Dermatology Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Dermatology Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Dermatology Drug Market Size by Region
4.1.1 Global Dermatology Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Dermatology Drug Revenue by Region (2016-2026)
4.2 North America Dermatology Drug Revenue (2016-2026)
4.3 Europe Dermatology Drug Revenue (2016-2026)
4.4 Asia-Pacific Dermatology Drug Revenue (2016-2026)
4.5 South America Dermatology Drug Revenue (2016-2026)
4.6 Middle East and Africa Dermatology Drug Revenue (2016-2026)
5 MARKET SEGMENT BY TYPE
5.1 Global Dermatology Drug Sales in Volume by Type (2016-2026)
5.2 Global Dermatology Drug Revenue by Type (2016-2026)
5.3 Global Dermatology Drug Price by Type (2016-2026)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Dermatology Drug Sales in Volume by Application (2016-2026)
6.2 Global Dermatology Drug Revenue by Application (2016-2026)
6.3 Global Dermatology Drug Price by Application (2016-2026)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Dermatology Drug Sales by Type (2016-2026)
7.2 North America Dermatology Drug Sales by Application (2016-2026)
7.3 North America Dermatology Drug Market Size by Country
7.3.1 North America Dermatology Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Dermatology Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Dermatology Drug Sales by Type (2016-2026)
8.2 Europe Dermatology Drug Sales by Application (2016-2026)
8.3 Europe Dermatology Drug Market Size by Country
8.3.1 Europe Dermatology Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Dermatology Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 ASIA-PACIFIC BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Dermatology Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Dermatology Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Dermatology Drug Market Size by Region
9.3.1 Asia-Pacific Dermatology Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Dermatology Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 South America Dermatology Drug Sales by Type (2016-2026)
10.2 South America Dermatology Drug Sales by Application (2016-2026)
10.3 South America Dermatology Drug Market Size by Country
10.3.1 South America Dermatology Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Dermatology Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Dermatology Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Dermatology Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Dermatology Drug Market Size by Country
11.3.1 Middle East & Africa Dermatology Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Dermatology Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Dermatology Drug Typical Distributors
12.3 Dermatology Drug Typical Customers
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Dermatology Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dermatology Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 External Use
1.2.3 Oral
1.2.4 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Dermatology Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Psoriasis
1.3.3 Skin Infections
1.3.4 Acne
1.3.5 Dermatitis
1.3.6 Others
1.4 Global Dermatology Drug Market Size & Forecast
1.4.1 Global Dermatology Drug Sales in Value (2016-2026))
1.4.2 Global Dermatology Drug Sales in Volume (2016-2026)
1.4.3 Global Dermatology Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Dermatology Drug Production Capacity Analysis
1.5.1 Global Dermatology Drug Total Production Capacity (2016-2026)
1.5.2 Global Dermatology Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dermatology Drug Market Drivers
1.6.2 Dermatology Drug Market Restraints
1.6.3 Dermatology Drug Trends Analysis
2 MANUFACTURERS PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Dermatology Drug Product and Services
2.1.4 AbbVie Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Dermatology Drug Product and Services
2.2.4 Johnson & Johnson Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Dermatology Drug Product and Services
2.3.4 Bayer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Galderma
2.4.1 Galderma Details
2.4.2 Galderma Major Business
2.4.3 Galderma Dermatology Drug Product and Services
2.4.4 Galderma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb Dermatology Drug Product and Services
2.5.4 Bristol-Myers Squibb Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Dermatology Drug Product and Services
2.6.4 Novartis Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Dermatology Drug Product and Services
2.7.4 Pfizer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Merz Pharma
2.8.1 Merz Pharma Details
2.8.2 Merz Pharma Major Business
2.8.3 Merz Pharma Dermatology Drug Product and Services
2.8.4 Merz Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Valeant
2.9.1 Valeant Details
2.9.2 Valeant Major Business
2.9.3 Valeant Dermatology Drug Product and Services
2.9.4 Valeant Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 LEO Pharma
2.10.1 LEO Pharma Details
2.10.2 LEO Pharma Major Business
2.10.3 LEO Pharma Dermatology Drug Product and Services
2.10.4 LEO Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Dermatology Drug Product and Services
2.11.4 GlaxoSmithKline Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 DERMATOLOGY DRUG SALES BY MANUFACTURER
3.1 Global Dermatology Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Dermatology Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Dermatology Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Dermatology Drug Manufacturer Market Share
3.4.2 Top 6 Dermatology Drug Manufacturer Market Share
3.5 Global Dermatology Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Dermatology Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Dermatology Drug Market Size by Region
4.1.1 Global Dermatology Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Dermatology Drug Revenue by Region (2016-2026)
4.2 North America Dermatology Drug Revenue (2016-2026)
4.3 Europe Dermatology Drug Revenue (2016-2026)
4.4 Asia-Pacific Dermatology Drug Revenue (2016-2026)
4.5 South America Dermatology Drug Revenue (2016-2026)
4.6 Middle East and Africa Dermatology Drug Revenue (2016-2026)
5 MARKET SEGMENT BY TYPE
5.1 Global Dermatology Drug Sales in Volume by Type (2016-2026)
5.2 Global Dermatology Drug Revenue by Type (2016-2026)
5.3 Global Dermatology Drug Price by Type (2016-2026)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Dermatology Drug Sales in Volume by Application (2016-2026)
6.2 Global Dermatology Drug Revenue by Application (2016-2026)
6.3 Global Dermatology Drug Price by Application (2016-2026)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Dermatology Drug Sales by Type (2016-2026)
7.2 North America Dermatology Drug Sales by Application (2016-2026)
7.3 North America Dermatology Drug Market Size by Country
7.3.1 North America Dermatology Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Dermatology Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Dermatology Drug Sales by Type (2016-2026)
8.2 Europe Dermatology Drug Sales by Application (2016-2026)
8.3 Europe Dermatology Drug Market Size by Country
8.3.1 Europe Dermatology Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Dermatology Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 ASIA-PACIFIC BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Dermatology Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Dermatology Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Dermatology Drug Market Size by Region
9.3.1 Asia-Pacific Dermatology Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Dermatology Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 South America Dermatology Drug Sales by Type (2016-2026)
10.2 South America Dermatology Drug Sales by Application (2016-2026)
10.3 South America Dermatology Drug Market Size by Country
10.3.1 South America Dermatology Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Dermatology Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Dermatology Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Dermatology Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Dermatology Drug Market Size by Country
11.3.1 Middle East & Africa Dermatology Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Dermatology Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Dermatology Drug Typical Distributors
12.3 Dermatology Drug Typical Customers
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Dermatology Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Dermatology Drug Revenue by Application, (USD Million), 2021-2026
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Dermatology Drug Product and Services
Table 6. AbbVie Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Dermatology Drug Product and Services
Table 10. Johnson & Johnson Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Dermatology Drug Product and Services
Table 14. Bayer Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Galderma Basic Information, Manufacturing Base and Competitors
Table 16. Galderma Major Business
Table 17. Galderma Dermatology Drug Product and Services
Table 18. Galderma Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb Major Business
Table 21. Bristol-Myers Squibb Dermatology Drug Product and Services
Table 22. Bristol-Myers Squibb Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Dermatology Drug Product and Services
Table 26. Novartis Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Dermatology Drug Product and Services
Table 30. Pfizer Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Merz Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Merz Pharma Major Business
Table 33. Merz Pharma Dermatology Drug Product and Services
Table 34. Merz Pharma Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Valeant Basic Information, Manufacturing Base and Competitors
Table 36. Valeant Major Business
Table 37. Valeant Dermatology Drug Product and Services
Table 38. Valeant Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 40. LEO Pharma Major Business
Table 41. LEO Pharma Dermatology Drug Product and Services
Table 42. LEO Pharma Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Major Business
Table 45. GlaxoSmithKline Dermatology Drug Product and Services
Table 46. GlaxoSmithKline Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Dermatology Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Dermatology Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Dermatology Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Dermatology Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Dermatology Drug Production Site of Key Manufacturer
Table 52. Dermatology Drug New Entrant and Capacity Expansion Plans
Table 53. Dermatology Drug Mergers & Acquisitions in the Past Five Years
Table 54. Global Dermatology Drug Sales by Region (2016-2021e) & (K Units)
Table 55. Global Dermatology Drug Sales by Region (2021-2026) & (K Units)
Table 56. Global Dermatology Drug Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Dermatology Drug Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Dermatology Drug Sales by Type (2016-2021e) & (K Units)
Table 59. Global Dermatology Drug Sales by Type (2021-2026) & (K Units)
Table 60. Global Dermatology Drug Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Dermatology Drug Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Dermatology Drug Price by Type (2016-2021e) & (USD/Unit)
Table 63. Global Dermatology Drug Price by Type (2021-2026) & (USD/Unit)
Table 64. Global Dermatology Drug Sales by Application (2016-2021e) & (K Units)
Table 65. Global Dermatology Drug Sales by Application (2021-2026) & (K Units)
Table 66. Global Dermatology Drug Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Dermatology Drug Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Dermatology Drug Price by Application (2016-2021e) & (USD/Unit)
Table 69. Global Dermatology Drug Price by Application (2021-2026) & (USD/Unit)
Table 70. North America Dermatology Drug Sales by Country (2016-2021e) & (K Units)
Table 71. North America Dermatology Drug Sales by Country (2021-2026) & (K Units)
Table 72. North America Dermatology Drug Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Dermatology Drug Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Dermatology Drug Sales by Type (2016-2021e) & (K Units)
Table 75. North America Dermatology Drug Sales by Type (2021-2026) & (K Units)
Table 76. North America Dermatology Drug Sales by Application (2016-2021e) & (K Units)
Table 77. North America Dermatology Drug Sales by Application (2021-2026) & (K Units)
Table 78. Europe Dermatology Drug Sales by Country (2016-2021e) & (K Units)
Table 79. Europe Dermatology Drug Sales by Country (2021-2026) & (K Units)
Table 80. Europe Dermatology Drug Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Dermatology Drug Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Dermatology Drug Sales by Type (2016-2021e) & (K Units)
Table 83. Europe Dermatology Drug Sales by Type (2021-2026) & (K Units)
Table 84. Europe Dermatology Drug Sales by Application (2016-2021e) & (K Units)
Table 85. Europe Dermatology Drug Sales by Application (2021-2026) & (K Units)
Table 86. Asia-Pacific Dermatology Drug Sales by Region (2016-2021e) & (K Units)
Table 87. Asia-Pacific Dermatology Drug Sales by Region (2021-2026) & (K Units)
Table 88. Asia-Pacific Dermatology Drug Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Dermatology Drug Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Dermatology Drug Sales by Type (2016-2021e) & (K Units)
Table 91. Asia-Pacific Dermatology Drug Sales by Type (2021-2026) & (K Units)
Table 92. Asia-Pacific Dermatology Drug Sales by Application (2016-2021e) & (K Units)
Table 93. Asia-Pacific Dermatology Drug Sales by Application (2021-2026) & (K Units)
Table 94. South America Dermatology Drug Sales by Country (2016-2021e) & (K Units)
Table 95. South America Dermatology Drug Sales by Country (2021-2026) & (K Units)
Table 96. South America Dermatology Drug Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Dermatology Drug Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Dermatology Drug Sales by Type (2016-2021e) & (K Units)
Table 99. South America Dermatology Drug Sales by Type (2021-2026) & (K Units)
Table 100. South America Dermatology Drug Sales by Application (2016-2021e) & (K Units)
Table 101. South America Dermatology Drug Sales by Application (2021-2026) & (K Units)
Table 102. Middle East & Africa Dermatology Drug Sales by Country (2016-2021e) & (K Units)
Table 103. Middle East & Africa Dermatology Drug Sales by Country (2021-2026) & (K Units)
Table 104. Middle East & Africa Dermatology Drug Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Dermatology Drug Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Dermatology Drug Sales by Type (2016-2021e) & (K Units)
Table 107. Middle East & Africa Dermatology Drug Sales by Type (2021-2026) & (K Units)
Table 108. Middle East & Africa Dermatology Drug Sales by Application (2016-2021e) & (K Units)
Table 109. Middle East & Africa Dermatology Drug Sales by Application (2021-2026) & (K Units)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Dermatology Drug Typical Distributors
Table 113. Dermatology Drug Typical Customers
Table 1. Global Dermatology Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Dermatology Drug Revenue by Application, (USD Million), 2021-2026
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Dermatology Drug Product and Services
Table 6. AbbVie Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Dermatology Drug Product and Services
Table 10. Johnson & Johnson Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Dermatology Drug Product and Services
Table 14. Bayer Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Galderma Basic Information, Manufacturing Base and Competitors
Table 16. Galderma Major Business
Table 17. Galderma Dermatology Drug Product and Services
Table 18. Galderma Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb Major Business
Table 21. Bristol-Myers Squibb Dermatology Drug Product and Services
Table 22. Bristol-Myers Squibb Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Dermatology Drug Product and Services
Table 26. Novartis Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Dermatology Drug Product and Services
Table 30. Pfizer Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Merz Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Merz Pharma Major Business
Table 33. Merz Pharma Dermatology Drug Product and Services
Table 34. Merz Pharma Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Valeant Basic Information, Manufacturing Base and Competitors
Table 36. Valeant Major Business
Table 37. Valeant Dermatology Drug Product and Services
Table 38. Valeant Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 40. LEO Pharma Major Business
Table 41. LEO Pharma Dermatology Drug Product and Services
Table 42. LEO Pharma Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Major Business
Table 45. GlaxoSmithKline Dermatology Drug Product and Services
Table 46. GlaxoSmithKline Dermatology Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Dermatology Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Dermatology Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Dermatology Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Dermatology Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Dermatology Drug Production Site of Key Manufacturer
Table 52. Dermatology Drug New Entrant and Capacity Expansion Plans
Table 53. Dermatology Drug Mergers & Acquisitions in the Past Five Years
Table 54. Global Dermatology Drug Sales by Region (2016-2021e) & (K Units)
Table 55. Global Dermatology Drug Sales by Region (2021-2026) & (K Units)
Table 56. Global Dermatology Drug Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Dermatology Drug Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Dermatology Drug Sales by Type (2016-2021e) & (K Units)
Table 59. Global Dermatology Drug Sales by Type (2021-2026) & (K Units)
Table 60. Global Dermatology Drug Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Dermatology Drug Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Dermatology Drug Price by Type (2016-2021e) & (USD/Unit)
Table 63. Global Dermatology Drug Price by Type (2021-2026) & (USD/Unit)
Table 64. Global Dermatology Drug Sales by Application (2016-2021e) & (K Units)
Table 65. Global Dermatology Drug Sales by Application (2021-2026) & (K Units)
Table 66. Global Dermatology Drug Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Dermatology Drug Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Dermatology Drug Price by Application (2016-2021e) & (USD/Unit)
Table 69. Global Dermatology Drug Price by Application (2021-2026) & (USD/Unit)
Table 70. North America Dermatology Drug Sales by Country (2016-2021e) & (K Units)
Table 71. North America Dermatology Drug Sales by Country (2021-2026) & (K Units)
Table 72. North America Dermatology Drug Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Dermatology Drug Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Dermatology Drug Sales by Type (2016-2021e) & (K Units)
Table 75. North America Dermatology Drug Sales by Type (2021-2026) & (K Units)
Table 76. North America Dermatology Drug Sales by Application (2016-2021e) & (K Units)
Table 77. North America Dermatology Drug Sales by Application (2021-2026) & (K Units)
Table 78. Europe Dermatology Drug Sales by Country (2016-2021e) & (K Units)
Table 79. Europe Dermatology Drug Sales by Country (2021-2026) & (K Units)
Table 80. Europe Dermatology Drug Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Dermatology Drug Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Dermatology Drug Sales by Type (2016-2021e) & (K Units)
Table 83. Europe Dermatology Drug Sales by Type (2021-2026) & (K Units)
Table 84. Europe Dermatology Drug Sales by Application (2016-2021e) & (K Units)
Table 85. Europe Dermatology Drug Sales by Application (2021-2026) & (K Units)
Table 86. Asia-Pacific Dermatology Drug Sales by Region (2016-2021e) & (K Units)
Table 87. Asia-Pacific Dermatology Drug Sales by Region (2021-2026) & (K Units)
Table 88. Asia-Pacific Dermatology Drug Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Dermatology Drug Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Dermatology Drug Sales by Type (2016-2021e) & (K Units)
Table 91. Asia-Pacific Dermatology Drug Sales by Type (2021-2026) & (K Units)
Table 92. Asia-Pacific Dermatology Drug Sales by Application (2016-2021e) & (K Units)
Table 93. Asia-Pacific Dermatology Drug Sales by Application (2021-2026) & (K Units)
Table 94. South America Dermatology Drug Sales by Country (2016-2021e) & (K Units)
Table 95. South America Dermatology Drug Sales by Country (2021-2026) & (K Units)
Table 96. South America Dermatology Drug Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Dermatology Drug Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Dermatology Drug Sales by Type (2016-2021e) & (K Units)
Table 99. South America Dermatology Drug Sales by Type (2021-2026) & (K Units)
Table 100. South America Dermatology Drug Sales by Application (2016-2021e) & (K Units)
Table 101. South America Dermatology Drug Sales by Application (2021-2026) & (K Units)
Table 102. Middle East & Africa Dermatology Drug Sales by Country (2016-2021e) & (K Units)
Table 103. Middle East & Africa Dermatology Drug Sales by Country (2021-2026) & (K Units)
Table 104. Middle East & Africa Dermatology Drug Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Dermatology Drug Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Dermatology Drug Sales by Type (2016-2021e) & (K Units)
Table 107. Middle East & Africa Dermatology Drug Sales by Type (2021-2026) & (K Units)
Table 108. Middle East & Africa Dermatology Drug Sales by Application (2016-2021e) & (K Units)
Table 109. Middle East & Africa Dermatology Drug Sales by Application (2021-2026) & (K Units)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Dermatology Drug Typical Distributors
Table 113. Dermatology Drug Typical Customers
LIST OF FIGURES
Figure 1. Dermatology Drug Picture
Figure 2. Global Dermatology Drug Sales Market Share by Type in 2020
Figure 3. External Use
Figure 4. Oral
Figure 5. Injection
Figure 6. Global Dermatology Drug Sales Market Share by Application in 2020
Figure 7. Psoriasis
Figure 8. Skin Infections
Figure 9. Acne
Figure 10. Dermatitis
Figure 11. Others
Figure 12. Global Dermatology Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Dermatology Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Dermatology Drug Sales (2016-2026) & (K Units)
Figure 15. Global Dermatology Drug Price by Type (2016-2026) & (USD/Unit)
Figure 16. Global Dermatology Drug Production Capacity (2016-2026) & (K Units)
Figure 17. Global Dermatology Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Dermatology Drug Market Drivers
Figure 19. Dermatology Drug Market Restraints
Figure 20. Dermatology Drug Market Trends
Figure 21. Global Dermatology Drug Sales Market Share by Manufacturer in 2020
Figure 22. Global Dermatology Drug Revenue Market Share by Manufacturer in 2020
Figure 23. Dermatology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Dermatology Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Dermatology Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Dermatology Drug Sales Market Share by Region (2016-2026)
Figure 27. Global Dermatology Drug Revenue Market Share by Region (2016-2026)
Figure 28. North America Dermatology Drug Revenue (2016-2026) & (USD Million)
Figure 29. Europe Dermatology Drug Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Dermatology Drug Revenue (2016-2026) & (USD Million)
Figure 31. South America Dermatology Drug Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Dermatology Drug Revenue (2016-2026) & (USD Million)
Figure 33. Global Dermatology Drug Sales Market Share by Type (2016-2026)
Figure 34. Global Dermatology Drug Revenue Market Share by Type (2016-2026)
Figure 35. Global Dermatology Drug Price by Type (2016-2026) & (USD/Unit)
Figure 36. Global Dermatology Drug Sales Market Share by Application (2016-2026)
Figure 37. Global Dermatology Drug Revenue Market Share by Application (2016-2026)
Figure 38. Global Dermatology Drug Price by Application (2016-2026) & (USD/Unit)
Figure 39. North America Dermatology Drug Sales Market Share by Type (2016-2026)
Figure 40. North America Dermatology Drug Sales Market Share by Application (2016-2026)
Figure 41. North America Dermatology Drug Sales Market Share by Country (2016-2026)
Figure 42. North America Dermatology Drug Revenue Market Share by Country (2016-2026)
Figure 43. United States Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Dermatology Drug Sales Market Share by Type (2016-2026)
Figure 47. Europe Dermatology Drug Sales Market Share by Application (2016-2026)
Figure 48. Europe Dermatology Drug Sales Market Share by Country (2016-2026)
Figure 49. Europe Dermatology Drug Revenue Market Share by Country (2016-2026)
Figure 50. Germany Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Dermatology Drug Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Dermatology Drug Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Dermatology Drug Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Dermatology Drug Revenue Market Share by Region (2016-2026)
Figure 59. China Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Dermatology Drug Sales Market Share by Type (2016-2026)
Figure 66. South America Dermatology Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Dermatology Drug Sales Market Share by Country (2016-2026)
Figure 68. South America Dermatology Drug Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Dermatology Drug Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Dermatology Drug Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Dermatology Drug Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Dermatology Drug Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Figure 1. Dermatology Drug Picture
Figure 2. Global Dermatology Drug Sales Market Share by Type in 2020
Figure 3. External Use
Figure 4. Oral
Figure 5. Injection
Figure 6. Global Dermatology Drug Sales Market Share by Application in 2020
Figure 7. Psoriasis
Figure 8. Skin Infections
Figure 9. Acne
Figure 10. Dermatitis
Figure 11. Others
Figure 12. Global Dermatology Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Dermatology Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Dermatology Drug Sales (2016-2026) & (K Units)
Figure 15. Global Dermatology Drug Price by Type (2016-2026) & (USD/Unit)
Figure 16. Global Dermatology Drug Production Capacity (2016-2026) & (K Units)
Figure 17. Global Dermatology Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Dermatology Drug Market Drivers
Figure 19. Dermatology Drug Market Restraints
Figure 20. Dermatology Drug Market Trends
Figure 21. Global Dermatology Drug Sales Market Share by Manufacturer in 2020
Figure 22. Global Dermatology Drug Revenue Market Share by Manufacturer in 2020
Figure 23. Dermatology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Dermatology Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Dermatology Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Dermatology Drug Sales Market Share by Region (2016-2026)
Figure 27. Global Dermatology Drug Revenue Market Share by Region (2016-2026)
Figure 28. North America Dermatology Drug Revenue (2016-2026) & (USD Million)
Figure 29. Europe Dermatology Drug Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Dermatology Drug Revenue (2016-2026) & (USD Million)
Figure 31. South America Dermatology Drug Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Dermatology Drug Revenue (2016-2026) & (USD Million)
Figure 33. Global Dermatology Drug Sales Market Share by Type (2016-2026)
Figure 34. Global Dermatology Drug Revenue Market Share by Type (2016-2026)
Figure 35. Global Dermatology Drug Price by Type (2016-2026) & (USD/Unit)
Figure 36. Global Dermatology Drug Sales Market Share by Application (2016-2026)
Figure 37. Global Dermatology Drug Revenue Market Share by Application (2016-2026)
Figure 38. Global Dermatology Drug Price by Application (2016-2026) & (USD/Unit)
Figure 39. North America Dermatology Drug Sales Market Share by Type (2016-2026)
Figure 40. North America Dermatology Drug Sales Market Share by Application (2016-2026)
Figure 41. North America Dermatology Drug Sales Market Share by Country (2016-2026)
Figure 42. North America Dermatology Drug Revenue Market Share by Country (2016-2026)
Figure 43. United States Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Dermatology Drug Sales Market Share by Type (2016-2026)
Figure 47. Europe Dermatology Drug Sales Market Share by Application (2016-2026)
Figure 48. Europe Dermatology Drug Sales Market Share by Country (2016-2026)
Figure 49. Europe Dermatology Drug Revenue Market Share by Country (2016-2026)
Figure 50. Germany Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Dermatology Drug Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Dermatology Drug Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Dermatology Drug Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Dermatology Drug Revenue Market Share by Region (2016-2026)
Figure 59. China Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Dermatology Drug Sales Market Share by Type (2016-2026)
Figure 66. South America Dermatology Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Dermatology Drug Sales Market Share by Country (2016-2026)
Figure 68. South America Dermatology Drug Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Dermatology Drug Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Dermatology Drug Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Dermatology Drug Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Dermatology Drug Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Dermatology Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
